These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2652512)

  • 41. Nocardia infection in a renal transplant unit.
    Leaker B; Hellyar A; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2103-4. PubMed ID: 2652677
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles: an assessment of cyclosporine, azathioprine/prednisolone, and triple therapy.
    McWhinnie DL; Azevedo LS; Carter NP; Cranston D; Jones R; Wood RF; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1633-4. PubMed ID: 3152633
    [No Abstract]   [Full Text] [Related]  

  • 43. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
    [No Abstract]   [Full Text] [Related]  

  • 44. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
    Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical use of mizoribine (Bredinin) and pharmacologic monitoring assessment in renal transplantation.
    Zaoui P; Serre-Debeauvais F; Bayle F; Bessard G; Pintar P; Deteix P; Janbon B; Vialtel P
    Transplant Proc; 1995 Feb; 27(1):1064-5. PubMed ID: 7878806
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract]   [Full Text] [Related]  

  • 47. The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial).
    Cho DK; Kim JH; Park SH; Kim JC; Kim CD; Baek MY; Kim SJ; Kim SH; Kwon TH; Kim YL; Kim YW; Chang SK
    Transplant Proc; 2001; 33(7-8):3256-8. PubMed ID: 11750394
    [No Abstract]   [Full Text] [Related]  

  • 48. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 50. Triple therapy improves the survival of cadaver renal allografts affected by acute tubular necrosis.
    Bakran A; Johnson RW; Dyer PA; Mallick NP; Gokal R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1278-9. PubMed ID: 2652423
    [No Abstract]   [Full Text] [Related]  

  • 51. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy.
    Maachi K; Berthoux P; Burgard G; Alamartine E; Berthoux F
    Transplant Proc; 1995 Feb; 27(1):846-9. PubMed ID: 7879202
    [No Abstract]   [Full Text] [Related]  

  • 52. Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.
    Todo S; Demetris AJ; Ueda Y; Imventarza O; Okuda K; Casavilla A; Cemaj S; Ghalab A; Mazzaferro V; Rhoe BS
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):57-61. PubMed ID: 2445076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experience with the use of mizoribine in human renal transplantation.
    Dohi K; Yahata H; Fukuda Y; Takenaka M; Tabe Y; Ono E; Fukuda M; Omotehara T; Eto T; Ezaki H
    Hiroshima J Med Sci; 1984 Dec; 33(4):809-12. PubMed ID: 6398817
    [No Abstract]   [Full Text] [Related]  

  • 54. Dual vs triple immunosuppressive therapy: equally safe and effective in kidney transplantation?
    Albrechtsen D; Flatmark A; Brynger H; Frødin L; Groth CG; Persson N
    Transplant Proc; 1991 Aug; 23(4):2206. PubMed ID: 1871845
    [No Abstract]   [Full Text] [Related]  

  • 55. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation.
    Walker RG; d'Apice AJ; Powell HR; Francis DM; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):7-10. PubMed ID: 3278465
    [No Abstract]   [Full Text] [Related]  

  • 56. Prophylactic treatment of antibody-mediated rejection with high-dose mizoribine and pharmacokinetic study.
    Liu D; Kobayashi T; Nagasaka T; Miwa Y; Ma Y; Yokoyama I; Kuzuya T; Oikawa T; Morozumi K; Uchida K; Nakao A
    Transpl Int; 2007 Apr; 20(4):365-70. PubMed ID: 17326777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advantages of triple therapy with mizoribine, cyclosporine and prednisolone over other types of triple and/or double therapy including cyclosporine for renal transplantation.
    Uchida H; Mita K; Bekku Y; Nishimura Y; Ishida Y; Watanabe K; Tomikawa S; Inoue S; Sugimoto H; Nagao T
    J Toxicol Sci; 1991 Nov; 16(4):181-90. PubMed ID: 1798064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined immunosuppression with low-dose cyclosporine, mizoribine, and prednisolone.
    Takahara S; Fukunishi T; Kokado Y; Ichikawa Y; Ishibashi M; Nagano S; Sonoda T
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):147-51. PubMed ID: 3291230
    [No Abstract]   [Full Text] [Related]  

  • 59. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 60. Low-dose cyclosporin, prednisolone and anti-lymphocyte globulin immunosuppressive treatment in cadaveric kidney transplantation.
    Ono Y; Ohshima S; Fujita T; Kinukawa T; Matsuura O; Hirabayashi S; Takeuchi N
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1657-9. PubMed ID: 2652543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.